CompoAtlas

Women’s Multivitamin Gummies

Food supplement declared in France, decision dated 11 August 2025

Women’s Multivitamin Gummies (NOVOMINS) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Lactobacillus Acidophilus LA85 1,000,000 (unit not declared) per day, Bifidobacterium Infantis BL21 1,000,000 (unit not declared) per day, Pantothenic acid (vitamin B5), Biotin (vitamin B8), Calcium. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
NOVOMINS
Food business operator placing the product on the market
INNOCENT HEALTH LTD
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Chewing gum
Daily dose
2 gommes
Directions for use
Prendre 2 gommes par jour ou selon les recommandations de votre professionnel de santé.
Flavourings
mûre

Declaration 338282, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
collagènenot declared

Other active ingredients

NamePer day
Bitartrate de cholinenot declared
Fibres d'agrumesnot declared
Ubiquinonenot declared
Hyaluronate de sodiumnot declared

Micro-organisms

StrainPer day
Lactobacillus Acidophilus LA851,000,000 (unit not declared)
Bifidobacterium Infantis BL211,000,000 (unit not declared)

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
calcium salts of orthophosphoric acidCalcium2,500 mg800 mg
chromium picolinateChromiumno limit (insufficient data)25 µg
cupric gluconateCopper5,000 µg2,000 µg
pteroylmonoglutamic acidFolate (vitamin B9)1,000 µg200 µg
potassium iodideIodine600 µg150 µg
sodium seleniteSelenium255 µg50 µg
retinyl acetateVitamin A3,000 µg d'équivalent rétinol800 µg
cyanocobalaminVitamin B12no adverse effect defineddose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg
cholecalciferolVitamin D100 µg (4,000 IU)5 µg (200 IU)
DL-alpha-tocopheryl acetateVitamin E300 mg30 mg
menaquinoneVitamin Kno limit (insufficient data)dose annulled by the French Council of State in 2011
zinc citrateZinc25 mg15 mg

Additives

E903, E331, E330, E440, E960, E1200, E953, E965

Other ingredients

jus de carotte, Huile de coco

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Les compléments alimentaires ne doivent pas être utilisés en remplacement d'une alimentation équilibrée et variée et d'un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Si vous êtes prenez des médicaments ou êtes sous surveillance médicale, veuillez consulter votre médecin ou un professionnel de la santé avant toute utilisation. Cessez l’utilisation et contactez un médecin immédiatement si des eets indésirables se produisent. Les gummies sont destinés à être mâchés et non à être avalés entiers. Déconseillé aux femmes enceintes ou désireuses de l’être. Déconseillé aux femmes ménopausées. Déconseillé aux personnes sous traitement anticoagulant. Déconseillé aux personnes souffrant de troubles de la thyroïde. Usage prolongé déconseillé. Réservée aux adultes. Ce produit ne convient pas aux végétariens. Une consommation excessive peut avoir des effets laxatifs.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ubiquinone
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    Sources cited by Health Canada (2)
    • Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
    • Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (3)
    • Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : NOVOMINS

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Women’s Multivitamin Gummies (NOVOMINS): composition and regulation”, https://compoatlas.com/en/supplements/products/338282-women-s-multivitamin-gummies, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line